The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in
the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the …

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …

Nonalcoholic fatty liver disease (NAFLD) has become the dominant form of chronic liver
disease in children and adolescents with the increasing prevalence of obesity worldwide …

Background Intestinal microbiota and their metabolites (eg short-chain fatty acids (SCFAs))
may influence nonalcoholic fatty liver disease (NAFLD). Objective The objective of this …

Nonalcoholic fatty liver disease (NAFLD) is a chronic condition affecting one quarter of the
global population. Although primarily linked to obesity and metabolic syndrome …

Non-alcoholic fatty liver disease (NAFLD) is a challenging disease caused by multiple
factors, which may partly explain why it remains still orphan of an adequate therapeutic …

The prevalence of non-alcoholic fatty liver disease (NAFLD) has soared globally. As our
understanding of the disease grows, the role of the gut-liver axis (GLA) in NAFLD …

Non-alcoholic fatty liver disease (NAFLD) is a metabolic stress liver injury that is closely
related to obesity, insulin resistance, type 2 diabetes, atherosclerosis, and metabolic …

The gut-brain axis is a bidirectional information interaction system between the central
nervous system (CNS) and the gastrointestinal tract, in which gut microbiota plays a key role …

Non-alcoholic fatty liver disease (NAFLD) is a widespread contributor to chronic liver
disease globally. A recent consensus on renaming liver disease was established, and …